HealthcarePress Releases

Scar Treatment Market Value to Reach US$ 61.9 Billion By 2030

Share This Article

The scar treatment market was exceeded US$ 20.6 billion in 2020 and is projected to reach US$ 61.9 billion by 2030, expanding at an annual CAGR of 10.7 percent, according to a 2021 study by Precedence Research, the Canada-based market Insight Company. The report contains 150+ pages with detailed analysis.

The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The dairy products market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1303

Market Report Scope

Report Highlights Details
Market Size in 2020 USD 20.6 Billion
Growth Rate CAGR of 10.7% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Segments Covered Treatment Type, Scar Type, End Use, Region

Competition Landscape

In the final section of the research report, Precedence Research provided the global scar treatment market structure and a detailed competition landscape to provide a dashboard view of key players operating in the scar treatment market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.

Some of the major players in the scar treatment market include:

  • Bausch Health Companies, Inc.
  • Candela Corp.
  • Sonoma Pharmaceuticals, Inc.
  • Hologic, Inc.
  • Johnson & Johnson
  • Quantum, Inc.
  • CCA Industries, Inc.
  • Avita Medical Ltd.
  • Revitol Corp.
  • Scarguard Labs, LLC.

The demand for cosmetics and various scar removal products is increasing among the population. This is majorly due to the aesthetic appeal. Scars are among the top factors that stimulates the consumption of various scar treatment products. The scar treatment market is majorly driven by the growing cases of road accidents, burn injuries, stretch marks, and other reasons.

According to a data published by the Population Reference Bureau, every year, around 50 million individuals are injured due to road accidents. As per the American Burn Association, there are more than 485,000 burn injury cases reported in US every year. Therefore, the growing cases of burn injuries and road accidents are significantly boosting the growth of the scar treatment market across the globe. Moreover, the growing concerns among the young adults regarding their aesthetic appearances are primarily driving the market growth.

Crucial factors accountable for market growth are:

  • Rising personal disposable income
  • Growing concerns among the young population regarding their looks
  • Rising prevalence of skin diseases
  • Technological advancements in the scar treatment industry
  • Growing number of road accidents
  • Easy availability of topical scar treatment products as OTC products
  • Rising penetration of healthcare units in emerging countries

Report Highlights

  • By treatment type, the laser segment is anticipated to grow at a rapid pace during the forecast period. This is attributable to the growing awareness regarding the laser skin treatment. Moreover, it provides rapid, effective, and painless treatment of scars.
  • By scar type, the hypertrophic & keloid is anticipated to be the most opportunistic segment. The growing prevalence of keloid scars especially in the developed regions like North America and Europe, is estimated to boost the segment growth throughout the forecast period.
  • By end use, the home-use segment led the global scar treatment market with remarkable revenue share in 2020. The increasing popularity of e-pharmacy and other digital pharmacy platforms coupled with the increased penetration of retail pharmacies across the world has significantly contributed towards the establishment of this segment as a leading segment in the past.

Regional Snapshots

North America is the dominating scar treatment market owing to the increased prevalence of scars in the region. According to the NCBI, around 100 million patients acquire scars owing to the elective operations and after-trauma operations in the developed nations, annually. It is estimated that around 11 million people have keloid scars and around 4 million people have burns, of which over 70% of the affected population consists of children. Hence, the growing prevalence of scars coupled with improved healthcare access and demand for aesthetic improvement has fostered the growth of the scar treatment market in North America.

Asia Pacific is estimated to be the fastest-growing market owing to the increased prevalence of road accidents. As per the WHO, the maximum road accidents occur in the low and middle income countries due to the lack of better roadways. Moreover, in the nations like India, where the population of youth is higher than any other nation are expected to foster the market growth. The young population concerned about their looks is significantly propelling the demand for the scar treatment products in the region.

Market Segmentation

By Treatment Type

  • Topical
  • Laser
  • Surface
  • Surgical
  • Injectable

By Scar Type

  • Acne & Atrophic
  • Stretch Marks
  • Hypertrophic & Keloid
  • Contracture

By End Use

  • Dermatology Clinics
  • Home-Use
  • Hospitals

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Most Asked Questions –

  • What was the market size value of the scar treatment in 2020?
  • What is the expected market size by 2030?
  • What is the scar treatment market growth?
  • What are the key factors that positively influence market growth?
  • Who are the prominent players in the scar treatment market?

Why should you invest in this report?

If you are aiming to enter the global scar treatment market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for scar treatment are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1303

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Scar Treatment Market, By Treatment

7.1. Scar Treatment Market, by Treatment Type, 2021-2030

7.1.1. Topical

7.1.1.1. Market Revenue and Forecast (2019-2030)

7.1.2. Laser

7.1.2.1. Market Revenue and Forecast (2019-2030)

7.1.3. Surface

7.1.3.1. Market Revenue and Forecast (2019-2030)

7.1.4. Surgical

7.1.4.1. Market Revenue and Forecast (2019-2030)

7.1.5. Injectable

7.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Scar Treatment Market, By End Use

8.1. Scar Treatment Market, by End Use, 2021-2030

8.1.1. Dermatology Clinics

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Home-Use

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Hospitals

8.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Scar Treatment Market, By Scar 

9.1. Scar Treatment Market, by Scar, 2021-2030

9.1.1. Acne & Atrophic

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Stretch Marks

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Hypertrophic & Keloid

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Contracture

9.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Scar Treatment Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.1.2. Market Revenue and Forecast, by End Use (2019-2030)

10.1.3. Market Revenue and Forecast, by Scar (2019-2030)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.1.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.1.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.1.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.1.5.3. Market Revenue and Forecast, by Scar (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.2.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.3. Market Revenue and Forecast, by Scar (2019-2030)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.2.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.2.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.5.3. Market Revenue and Forecast, by Scar (2019-2030)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.2.6.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.6.3. Market Revenue and Forecast, by Scar (2019-2030)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.2.7.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.7.3. Market Revenue and Forecast, by Scar (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.3.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.3. Market Revenue and Forecast, by Scar (2019-2030)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.3.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.3.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.5.3. Market Revenue and Forecast, by Scar (2019-2030)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.3.6.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.6.3. Market Revenue and Forecast, by Scar (2019-2030)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.3.7.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.7.3. Market Revenue and Forecast, by Scar (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.4.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.4.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.5.3. Market Revenue and Forecast, by Scar (2019-2030)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.4.6.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.6.3. Market Revenue and Forecast, by Scar (2019-2030)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.4.7.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.7.3. Market Revenue and Forecast, by Scar (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.5.3. Market Revenue and Forecast, by Scar (2019-2030)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.5.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.5.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.5.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.5.5.3. Market Revenue and Forecast, by Scar (2019-2030)

Chapter 11. Company Profiles

11.1. Bausch Health Companies, Inc.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Candela Corp.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Sonoma Pharmaceuticals, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Hologic, Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Johnson & Johnson

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Quantum, Inc.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. CCA Industries, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Avita Medical Ltd.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Revitol Corp.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Scarguard Labs, LLC.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1303

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Follow us on LinkedIn | Twitter | Facebook

Show More

Market Stats News

Market Stats News is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services, we aim at connecting an organization’s goal with lucrative prospects globally.

Related Articles

Back to top button